Literature DB >> 25841360

Affect of antidepressants on the in vitro differentiation of rat bone marrow mesenchymal stem cells into neuronal cells.

Paulina Borkowska1, Joanna Kowalska2, Anna Fila-Danilow2, Anna Maria Bielecka3, Monika Paul-Samojedny2, Malgorzata Kowalczyk2, Jan Kowalski2.   

Abstract

BACKGROUND: Bone marrow is a valuable source of mesenchymal stem cells (MSCs) that can be used in regenerative medicine. MSCs are able to differentiate into cells from all three germ layers under specific conditions. The aim of the current work was to study the differentiation of rat MSCs (rMSCs) into neuron-like cells. NEW
METHOD: We investigated how the antidepressants imipramine, desipramine, fluoxetine and tianeptine affect the differentiation of rMSCs. Furthermore, we present differentiation cocktails using a cortex astrocyte-conditioned medium (CACM) separately or in conjunction with each of the antidepressants and investigated their additive effect on the efficiency of differentiation. We also observed how various differentiation conditions affect the number of primary dendrites and branching dendrites per cell.
RESULTS: Gene expression for an early neuronal marker (β-III-tubulin) and markers that are typical for adult neurons such as Th, Htr2A and Slc6a4 were observed. The Tubb3 and Htr2A gene expression were up-regulated, Th decreased slightly and Slc6a4 was down-regulated after differentiation We observed a two-fold higher percentage of β-III-tubulin positive cells after treatment with antidepressants and two-fold increase of neuron-like cells after using CACM with imipramine or fluoxetine simultaneously. Differentiation using imipramine or in conjunction with CACM and desipramine or fluoxetine simultaneously increased the number of cell dendrites. COMPARISON WITH EXISTING
METHODS: The results that were obtained are completely new and need further investigations in the nearest future.
CONCLUSIONS: These results suggest that antidepressants improve differentiation efficiency of rMSCs and may be useful in the preparation of rMSCs for transplantation. Differentiation efficiency is higher after long-term exposure to antidepressants, than after a 24-h exposure. Nearly additive effect of CACM and imipramine or fluoxetine suggests a beneficial role of antidepressants after transplantation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressants; Branching neurons; Differentiation; Mesenchymal stem cells; β-III-tubulin

Mesh:

Substances:

Year:  2015        PMID: 25841360     DOI: 10.1016/j.ejps.2015.03.016

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

Review 1.  Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.

Authors:  Princy Choudhary; Ayushi Gupta; Sangeeta Singh
Journal:  J Mol Neurosci       Date:  2020-10-13       Impact factor: 3.444

2.  Fluoxetine Decreases the Proliferation and Adipogenic Differentiation of Human Adipose-Derived Stem Cells.

Authors:  Bo Kyung Sun; Ji Hye Kim; Joon-Seok Choi; Sung-Joo Hwang; Jong-Hyuk Sung
Journal:  Int J Mol Sci       Date:  2015-07-22       Impact factor: 5.923

3.  Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells on periventricular leukomalacia-like brain injury in neonatal rats.

Authors:  Chikako Morioka; Motohiro Komaki; Atsuko Taki; Izumi Honda; Naoki Yokoyama; Kengo Iwasaki; Sachiko Iseki; Tomohiro Morio; Ikuo Morita
Journal:  Inflamm Regen       Date:  2017-01-16

4.  Growth characteristics of human bone marrow mesenchymal stromal cells at cultivation on synthetic polyelectrolyte nanofilms in vitro.

Authors:  Lyudmila M Mezhevikina; Dmitriy A Reshetnikov; Maria G Fomkina; Nurbol O Appazov; Saltanat Zh Ibadullayeva; Evgeniy E Fesenko
Journal:  Heliyon       Date:  2021-03-20

5.  Correlates of Post-Stroke Brain Plasticity, Relationship to Pathophysiological Settings and Implications for Human Proof-of-Concept Studies.

Authors:  Eduardo H Sanchez-Mendoza; Dirk Matthias Hermann
Journal:  Front Cell Neurosci       Date:  2016-08-05       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.